IL100266A - Imidazolyl-triazolyl- or tetrazolyl-A compounds Fluoromethylbenzene and their salts are aromatase inhibitors, a process for their preparation and pharmaceutical preparations containing them - Google Patents

Imidazolyl-triazolyl- or tetrazolyl-A compounds Fluoromethylbenzene and their salts are aromatase inhibitors, a process for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL100266A
IL100266A IL10026691A IL10026691A IL100266A IL 100266 A IL100266 A IL 100266A IL 10026691 A IL10026691 A IL 10026691A IL 10026691 A IL10026691 A IL 10026691A IL 100266 A IL100266 A IL 100266A
Authority
IL
Israel
Prior art keywords
formula
compound
triazolyl
cyano
lower alkyl
Prior art date
Application number
IL10026691A
Other languages
English (en)
Hebrew (he)
Other versions
IL100266A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL100266A0 publication Critical patent/IL100266A0/xx
Publication of IL100266A publication Critical patent/IL100266A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
IL10026691A 1990-12-12 1991-12-06 Imidazolyl-triazolyl- or tetrazolyl-A compounds Fluoromethylbenzene and their salts are aromatase inhibitors, a process for their preparation and pharmaceutical preparations containing them IL100266A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH392390 1990-12-12

Publications (2)

Publication Number Publication Date
IL100266A0 IL100266A0 (en) 1992-09-06
IL100266A true IL100266A (en) 1996-05-14

Family

ID=4266402

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10026691A IL100266A (en) 1990-12-12 1991-12-06 Imidazolyl-triazolyl- or tetrazolyl-A compounds Fluoromethylbenzene and their salts are aromatase inhibitors, a process for their preparation and pharmaceutical preparations containing them

Country Status (18)

Country Link
US (4) US5227393A (fr)
EP (1) EP0490816B1 (fr)
JP (1) JP3133432B2 (fr)
KR (1) KR100214353B1 (fr)
AT (1) ATE155130T1 (fr)
AU (1) AU649499B2 (fr)
CA (1) CA2057338C (fr)
DE (1) DE59108770D1 (fr)
DK (1) DK0490816T3 (fr)
ES (1) ES2104682T3 (fr)
GR (1) GR3024191T3 (fr)
IE (1) IE914312A1 (fr)
IL (1) IL100266A (fr)
NZ (1) NZ240925A (fr)
PH (1) PH30675A (fr)
PT (1) PT99738B (fr)
TW (1) TW210334B (fr)
ZA (1) ZA919752B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224461B (fr) * 1990-09-18 1994-06-01 Ciba Geigy Ag
TW210334B (fr) * 1990-12-12 1993-08-01 Ciba Geigy Ag
AU5285593A (en) * 1992-10-21 1994-05-09 Sankyo Company Limited Azole compound
US5426196A (en) * 1993-12-22 1995-06-20 Glaxo Inc. Synthesis of diaryl methanes
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
FI20010905A0 (fi) * 2001-05-02 2001-05-02 Vetcare Oy Uusi eläinlääke
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
US8969327B2 (en) 2010-04-08 2015-03-03 Emory University Substituted androst-4-ene diones
PT2753312T (pt) 2011-09-08 2017-02-03 Mereo Biopharma 2 Ltd Utilização de um inibidor da aromatase para o tratamento de hipogonadismo e doenças relacionadas
AU2015301891B2 (en) 2014-08-11 2019-12-05 Angion Biomedica Corporation Cytochrome P450 inhibitors and uses thereof
WO2016109492A1 (fr) 2014-12-31 2016-07-07 Angion Biomedica Corp Méthodes et agents pour traiter une maladie
GB201614179D0 (en) * 2016-08-19 2016-10-05 Mereo Biopharma 2 Ltd Dosage regimen for the treatment of endometriosis

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2407305C2 (de) * 1974-02-15 1984-06-28 Bayer Ag, 5090 Leverkusen Triphenyl-1,2,3-triazol-1-yl-methane, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
GB1511195A (en) * 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
GB1555417A (en) * 1977-04-19 1979-11-07 Ici America Inc Triazole compositions
NZ206968A (en) * 1983-02-02 1986-06-11 Lilly Co Eli Pyrimidine derivatives pharmaceutical formulations
US4762836A (en) * 1983-02-02 1988-08-09 Eli Lilly And Company Aromatase inhibitors
GB8305377D0 (en) * 1983-02-25 1983-03-30 Pfizer Ltd Antifungal agents
DE3572809D1 (de) * 1984-05-23 1989-10-12 Ciba Geigy Ag Microbicidal 1-fluoro-1-azolyl-2,2-diarylethane derivatives
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4845227A (en) * 1984-06-18 1989-07-04 Eli Lilly And Company Aromatase inhibitors from azoles
US4757076A (en) * 1984-06-18 1988-07-12 Eli Lilly And Company Method of inhibiting aromatase
US4764376A (en) * 1984-06-18 1988-08-16 Eli Lilly And Company Method of inhibiting aromatase
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5071861A (en) * 1986-03-07 1991-12-10 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
DE3627310A1 (de) * 1986-08-12 1988-02-18 Biotechnolog Forschung Gmbh Pyocyanin-derivate und herstellungsverfahren
JPS63165376A (ja) * 1986-12-27 1988-07-08 Nippon Soda Co Ltd オキサ（チア）ジアゾ−ル誘導体その製造方法及び殺ダニ剤
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
GB8716651D0 (en) * 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3819903A1 (de) * 1988-06-11 1989-12-21 Basf Ag 1-halogen-1-azolyl-ethan-derivate und diese enthaltende fungizide
GB8818561D0 (en) * 1988-08-04 1988-09-07 Ici Plc Diphenylethane derivatives
DE59010171D1 (de) * 1989-07-14 1996-04-11 Ciba Geigy Ag Substituierte Benzonitrile
EP0445073A1 (fr) * 1990-02-27 1991-09-04 Ciba-Geigy Ag Benzofurannes
TW224461B (fr) * 1990-09-18 1994-06-01 Ciba Geigy Ag
TW210334B (fr) * 1990-12-12 1993-08-01 Ciba Geigy Ag

Also Published As

Publication number Publication date
EP0490816A2 (fr) 1992-06-17
PT99738B (pt) 1999-05-31
EP0490816B1 (fr) 1997-07-09
US5637605A (en) 1997-06-10
PT99738A (pt) 1992-12-31
ATE155130T1 (de) 1997-07-15
US5376669A (en) 1994-12-27
JP3133432B2 (ja) 2001-02-05
JPH04300866A (ja) 1992-10-23
EP0490816A3 (en) 1992-12-02
KR100214353B1 (ko) 1999-08-02
IE914312A1 (en) 1992-06-17
US5227393A (en) 1993-07-13
US5457209A (en) 1995-10-10
ES2104682T3 (es) 1997-10-16
GR3024191T3 (en) 1997-10-31
TW210334B (fr) 1993-08-01
AU8889991A (en) 1992-07-09
IL100266A0 (en) 1992-09-06
CA2057338A1 (fr) 1992-06-13
AU649499B2 (en) 1994-05-26
DK0490816T3 (da) 1997-09-22
DE59108770D1 (de) 1997-08-14
ZA919752B (en) 1992-08-26
CA2057338C (fr) 2002-09-17
PH30675A (en) 1997-09-16
NZ240925A (en) 1995-02-24
KR920012049A (ko) 1992-07-25

Similar Documents

Publication Publication Date Title
AU654350B2 (en) Benzofuran derivatives
US5637605A (en) α-fluoro-α-1-(1,2,4-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors
EP0430709A2 (fr) Dérivés de benzothiophène
EP0434249A2 (fr) Dérivés de benzofurane
US5310927A (en) Benzofuran derivatives
US4914099A (en) Hydantoin derivatives as aldose reductase inhibitors
HU204801B (en) Process for producing tetrazolylmethylbenzo- or naphthonitriles and pharmaceutical compositions comprising same
CA2036975A1 (fr) Benzofuranes
JP4733692B2 (ja) Ｐｐａｒ活性化剤としてのピラゾールフェニル誘導体
KR20010030683A (ko) 1,5-디페닐피라졸 유도체
US5378721A (en) Heteroarylmethylbenzenes
HUT72311A (en) 5-(1,2,4-+triazol-1-yl-methyl)-3h-iso-benzofuran-1-one derivatives, their preparation and use as aromatase inhibitors and pharmaceutical compositions containing them
US5206256A (en) Naphthalene derivatives
IE921936A1 (en) Bicyclic-substituted vinylimidazoles, -triazoles and¹-tetrazoles
KR20200041852A (ko) 몰루긴 유도체 화합물, 및 이를 포함하는 염증성 장질환의 예방 또는 치료용 약학 조성물
AU2005219536A1 (en) Pyrazolyl indolyl derivatives as PPAR activators

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired